Together with Anna, Katrin is the Co-Lead of the GMP Development Unit at Fraunhofer IZI, and senior scientist and project manager at Fraunhofer IZI’s Cellular Immunotherapy group in Würzburg, affiliated with Universitätsklinikum Würzburg’s Cellular Immunotherapy Chair. She oversees preclinical development of CAR-modified immune cells—designing and optimizing all steps of manufacturing including bioreactor-based activation and expansion, non-viral gene transfer, and in depth phenotypical and functional characterization. Her work advances automated CAR-T production platforms (e.g., AIDPATH) to improve access, quality, and timing of personalized cancer therapies.

‍

‍